Introduction:
Inborn errors of metabolism cause hereditary metabolic diseases (HMD) and classically they result from the lack of activity of one or more specific enzymes or defects in the transportation of proteins. The consequences can usually be the accumulation of substances present in small amounts, the deficiency of critical intermediary products, the deficiency of specific final products or furthermore the noxious excess of products of alternative metabolic pathways. 1, 2 Over one third of the inherited metabolic disorders are characterized by the central nervous system involvement and neurological symptoms are the presenting and the most prominent clinical problems associated with them. 3 The main subgroups of neurological importance are disorders of amino acid and organic acid intermediary metabolism, lysosomal diseases, peroxisomal disorders and errors in energy metabolism especially the mitochondrial diseases. 4 All IEM are single-gene disorders, almost all being inherited in an autosomal recessive or X-linked recessive manner. 5 Primary mitochondrial respiratory chain disease is a heterogeneous group of disorders characterized by impaired energy metabolism due to presumed genetically-based oxidative phosphorylation (OXPHOS) dysfunction.
Although primary mitochondrial disease by definition has a genetic etiology, the genetic abnormality may be found in either mitochondrial DNA (mtDNA) or nuclear DNA (nDNA). 6 Clinical oiinters towards an underlying IEM include: deterioration after a period of apparent normal development, parental consanguinity, family history of unexplained neonatal deaths, rapidly progressive encephalopathy, seizures of unexplained cause, severe metabolic acidosis, persistent vomiting and peculiar odor. 7 The basic laboratory studies that should be obtained for an infant who has symptoms of a metabolic encephalopathy consistent with an inborn error of metabolism include: Complete blood count with differential, urinalysis, blood gases, serum electrolytes, blood glucose, plasma ammonia, urine reducing substances, urine ketones if acidosis or hypoglycemia present, plasma and urine amino acids, quantitative urine organic acids, plasma lactate. 8 Tandem mass spectrometry (MS/MS) is a powerful technology that allows a rapid and sensitive screening over more than thirty inborn errors of metabolism through measurement of amino acids and acylcarnitines in a small quantity of blood. 9 The aim of this study is to determine the association of consanguinity, regression or delay in development, seizures, EEG findings and other/step-wise laboratory investigations (ammonia, lactate and Tandem Mass Spectrometry (TMS)) in children suspected to have neurometabolic disorders, to aid clinicians working in resource-poor countries.
Methodology:
Retrospectively analysis was done regarding the demographic, clinical symptoms and laboratory (biochemical and electrophysiological) findings of 128 patients admitted in the Department of Pediatric Neurosciences, Dhaka Shishu Hospital during the period from December 2007 to February 2011 suspected of having inborn error of metabolism.
Early suspicion made by the presence of consanguinity, regression of developmental skills, unexplained developmental delay, sibling death, affected sibling and clinical manifestations of unexplained seizure, vomiting, encephalopathy, mental retardation, ataxia, spasticity and cutaneous abnormalities.
Almost all children of suspected neurometabolic disorder underwent a primary screening of serum ammonia, lactate, fasting blood sugar, electrolytes, SGPT, arterial blood gas and urinary ketones. Other tests included complete blood count, neuroimaging (USG, CT, MRI), electroencephalography (EEG). Children who had clinical findings for specific diseases didn't go for ammonia, lactate or TMS estimation eg. cherry red spot for Tay-Sachs disease, KayserFlescher ring for Wilson's disease, demyelination found in neuroimaging for leukodystrophy. Tandem mass spectrometry (TMS) was done where abnormality found in primary screening test. Biotinidase deficiency was suspected on the basis of TMS abnormality in a significant number of cases and serum biotinidase activity measured. Further tests suggested according to abnormalities found in TMS.
Patient's data were evaluated and categorized as age, sex, consanguinity, perinatal insult, sibling death, affected sibling, regression of development, developmental delay, seizure and level of ammonia, lactate, TMS and biotinidase activity in serum. The data were analyzed using descriptive method and no statistical testing was applied.
Results:
Among 128 analyzed children, 70 were given presumptive diagnosis of IEM based on positive screening tests. The age and sex wise distribution shows preponderance of males (64%) compared to females (36%). Age distribution showed that maximum participants were from the age group >1 to 5 years (53%) and only 16% cases were from the >5 years of age (Table-I) . Table -IV) . 
Discussion:
The investigation of infants and children with suspected inborn errors of metabolism and specifically inherited neurometabolic disorders is challenging in pediatric neurology practice.
Each infant/child deserves a detailed clinical and individual assessment. There is no standard battery of laboratory tests; thus, experience and multidisciplinary teamwork are of the utmost importance. 10 The male predominance is un-explained except for a possible gender bias in hospitalization of sick children.
Background history, mode of presentation and clinical examination was the important part of the initial evaluation. In the history there may be several important factors to suggest an IEM. The previous family history should be explored for evidence of consanguinity and unexplained neonatal or infantile deaths; this should include a three generation pedigree. 11 Most inborn errors of metabolism are inherited in an autosomal recessive fashion. In most of these cases, the disease can only manifest itself fully in homozygotes for the mutation. This is generally a rare occurrence, except in consanguineous families. 12 A positive family history and consanguinity were the most important pointers. In this study 39 (31%) cases had parental consanguinity. In Egypt, inborn errors of metabolism are common, presumably because of the high rates of consanguinity (38%). 13 Regression of development is one of the most important clinical presentation for the suspicion of NMD. The common scenario associated with metabolic disease is that of the child or infant who initially develops and grows well before developing symptoms. In our study 52 (41%) cases were presented with regression of previously acquired developmental skills. Developmental regression is significant and always needs investigation. 14 The commoner causes of developmental delay are chromosomal abnormalities and structural brain abnormalities. 15 One of the challenging questions for paediatricians investigating children with developmental delay is how intensively should one investigate for inborn errors of metabolism and which metabolic investigations are indicated.
Reports on the prevalence of inborn errors of metabolism (IEMs) as the underlying cause of delay show some variation but generally indicate that IEMs are found to be the cause in only a small percentage of these cases (that is, 1-5%). 16 Seizures were a predominant symptom among our study subjects. Seizures were associated with 96 (75%) children and abnormal EEG findings recorded in 83 (65%). Seizures are more likely to be uncontrolled in metabolic disorder.
Study from Vidya et al in India shows seizure in 26% cases. 17 Higher values (43%) were reported by Ilhem and coworkers, in Tunisia. 18 There is lack of metabolic screening Facilities in developing countries. A battery of four simple tests namely arterial blood gases, blood ammonia, urinary ketones and blood lactate are advocated in tertiary health care centers 19 Elevation of blood ammonia is usually caused by defects of urea cycle enzymes. Infants with elevated blood ammonia levels from urea cycle defects commonly have normal serum pH and bicarbonate values. Elevation of ammonia is also observed in some infants with certain organic acidemias Elevated lactate along with ketoacidosis with or without hyperammonnemiais seen in lactic acidosis. Ketoacidosis with or without elevated lactate along with hyperammonnemia points towards organic aciduria. 19, 20 The inborn errors of metabolism detected by tandem mass spectrometry generally include aminoacidemias, urea cycle disorders, organic acidurias, and fatty acid oxidation disorders. Earlier recognition of these inborn errors of metabolism has the potential to reduce morbidity and mortality rates in these infants. 21 Among 128 cases of suspected neurometabolic disorder TMS was done in 111 cases and abnormality found in 70 (63% Biotin is a very important vitamin that found in some foods. 25 Biotinidase deficiency is a rare and treatable inherited neurometabolic disorder with an estimated incidence of 1:61, 067 population. 26 This disorder in its severe form is much rarer with incidence of 1:137401. 27 In this study most of the cases were suspected as biotinidase deficiency based on TMS abnormality.
A precise diagnosis of neurometabolic disorder requires specific test. In our study specific enzyme estimation is done only in limited number of patients due to both unavailability of the test in our country or unaffordibility of the parents. Among the suspected disorders only biotinidase activity was done.
Conclusion:
Background history and clinical presentation followed by stepwise laboratory investigation is necessary to identify neurometabolic disorders. Definitive diagnosis by specified tests can be advised for those patients who are positive on screening tests. Early and appropriate intervention can reduce neurodisability in many situations consanguinity was twice as frequent in the study patients as compared to the general population.
